European Journal of Cardio-Thoracic Surgery · 2018 · 59 citations · 30 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyHemodynamic ManagementAortic RegurgitationAortic StenosisAortic SurgeryAortic Valve DiseaseCardiac Valve SurgeryAortic Valve Disease PrognosisAortic Valve RegurgitationBicuspid Aortic Valve StenosisFollow-up DurationInpatient Mortality
OBJECTIVES: The Ross procedure has demonstrated excellent results when performed in patients with aortic stenosis or mixed aortic valve disease [aortic stenosis and aortic regurgitation (AR)]. However, due to its reported risk of late reoperation, it is not recommended under current guidelines for patients presenting with bicuspid aortic valve and pure AR. We have analysed our own results in light of this recommendation. METHODS: Between 1993 and 2016, 129 consecutive patients with a mean age of 34.7 ± 10.6 years (range 16-64 years) presented with bicuspid aortic valve and pure AR and underwent the Ross procedure. Patients were reviewed annually and had 2nd yearly transthoracic echocardiograms during follow-up. The unit had a liberal reoperation policy where reoperation was performed if patients developed recurrent moderate or greater AR during follow-up. RESULTS: There was 1 inpatient death, and 3 late deaths over a mean follow-up duration of 9.6 ± 6.8 years. Late survival at 10 and 20 years post-surgery were 99% [95% confidence interval (CI) 94-100] and 95% (95% CI 85-99), respectively. Eleven patients underwent redo aortic valve replacement (AVR) and 4 patients had redo pulmonary valve replacement. Freedom from reoperation for AVR and more-than-mild AR at 10 and 20 years post-surgery were 89% (95% CI 81-94) and 85% (95% CI 74-92), respectively. Having longer aortic cross-clamp (hazard ratio 1.03, 95% CI 1.00-1.06; P = 0.05) and cardiopulmonary bypass times (hazard ratio 1.02, 95% CI 1.00-1.05; P = 0.05), and having a larger preoperative sinotubular junction diameter (hazard ratio 1.15, 95% CI 1.03-1.30; P = 0.02) were significant predictors of having redo AVR or significant AR at follow-up. CONCLUSIONS: With a 20-year freedom from redo AVR and greater-than-mild residual AR of 85%, the utilization of the Ross procedure in bicuspid aortic valve patients with pure AR should be considered.
30
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Helmut Baumgartner, Volkmar Falk, Jeroen J. Bax et al. · European Heart Journal · 2017 · 6.3K citations · Full text
Medicine, Cardiology, Surgery +14
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Rick A. Nishimura, Catherine M Otto, Robert O. Bonow et al. · Circulation · 2014 · 2.6K citations
Medicine, Cardiology, Surgery +16
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement
Andrew B. Goldstone, Peter Chiu, Michael Baiocchi et al. · New England Journal of Medicine · 2017 · 669 citations · Full text
Medicine, Cardiology, Surgery +10
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Volkmar Falk, Helmut Baumgartner, Jeroen J. Bax et al. · European Journal of Cardio-Thoracic Surgery · 2017 · 635 citations · Full text
Medicine, Cardiology, Surgery +14